Timber!!!!!, page-9

Gwil, it's blatantly apparent that Benitec needs to list on a major US exchange, where biotech companies get the respect and market caps they deserve. Granted, benitec is still in the midst of its first trial. However, if we were listed on a major US exchange, the last few days' news would have caused the sp to rise. There are biotech penny and sub penny stocks I've watched here in the states that have done better on less impressive news. Benitec has a portfolio that is huge in potential, IP, and soon, clinical data. Many may disagree with cool stocks, and sometimes I do as well. However, the sp will continue to be stagnant, and will never be fully appreciated on the ASX even with efficacy. We need to uplist.